Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ankle SSB is a specific regional anesthetic combination used for single-shot peripheral nerve blocks to manage postoperative pain following ankle fracture surgery. Developed and studied by NYU Langone Health, this formulation consists of a mixture of lidocaine (a fast-acting local anesthetic), bupivacaine (a long-acting local anesthetic), and epinephrine (a vasoconstrictor used to prolong the block's duration and reduce systemic absorption). It is typically administered via injection around the target nerves to provide immediate and sustained analgesia during the early postoperative period. The combination leverages the rapid onset of lidocaine and the extended duration of bupivacaine, while epinephrine enhances the efficacy and safety profile by localizing the drugs at the site of injection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + bupivacaine + epinephrine.